kjrh.com2h
Oklahoman sheds light on work of rescue crews on Potomac
Capt. Matt Wells, the program manager for Oklahoma Task Force 1, shared with 2 News Oklahoma's Brodie Myers, the intricacies ...
Levi & Korsinsky Reminds Shareholders of an Investigation into CARGO Therapeutics, Inc. (CRGX) Regarding Potential Securities Fraud Allegations
NEW YORK CITY, NY / ACCESS Newswire / January 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CARGO ...
Le Lézard10h
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CARGO Therapeutics, Inc. ("CARGO" or "the Company") for ...
Nike Is Offering Big Discounts on Popular Air Force 1 Sneakers, and Shoppers Say They ‘Love These Shoes'
Right now shoppers can grab the Nike Air Force 1 '07 for as low as $70 and the Nike Air Force 1 Shadow for as low as $82.
Amazon Is Selling Beats Studio Pro Headphones for 49% Off
One reviewer says, "Worth the Wait – Amazing Sound and Stunning Design!" ...
The Schall Law Firm Urges Shareholders With Losses To Join An Investigation Into CARGO Therapeutics, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
precisionmedicineonline17h
Cargo Therapeutics Nixes Phase II CAR T-Cell Study, Cuts Workforce by 50 Percent
The changes will extend the company's cash runway, enabling it to advance a tri-specific CAR T-cell candidate and its allogeneic cell therapy platform.
Meta Platforms, CVS Health upgraded: Wall Street's top analyst calls
Benchmark upgraded Meta Platforms (META) to Buy from Hold with a $820 price target, citing a "strong" 2025 core business ...
Cargo Therapeutics stock tumbles after trial setback
Investing.com -- Shares of CARGO Therapeutics , Inc. (NASDAQ: CRGX) plummeted 75% following the company's decision to discontinue its Phase 2 clinical trial for firicabtagene autoleucel, citing ...